Oncotarget

Vol 10, No 54

September 24, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 54 of Oncotarget features Figure 2, "Comparative proteomic profiling of the peptides/proteins identified from 293T, IL16lamp2b and mExo-Tat samples," by Lu, et al.

Table of Contents

Editorial

Intracellular acting tumor cell-targeted chemotherapy by MSC-suicide gene exosomes

Intracellular acting tumor cell-targeted chemotherapy by MSC-suicide gene exosomes

https://doi.org/10.18632/oncotarget.27135

Cestmir Altaner, Ursula Altanerova,  and Jana Jakubechova
5573-5575
PDF  |  How to cite  |  Order a Reprint

Research Papers

Targeting transcription factor TCF4 by γ-Mangostin, a natural xanthone

Targeting transcription factor TCF4 by γ-Mangostin, a natural xanthone

https://doi.org/10.18632/oncotarget.27159

Balaji Krishnamachary, Dharmalingam Subramaniam, Prasad Dandawate, Sivapriya Ponnurangam, Pugazhendhi Srinivasan, Prabhu Ramamoorthy, Shahid Umar, Sufi Mary Thomas, Animesh Dhar, Seth Septer, Scott J. Weir, Thomas Attard,  and Shrikant Anant
5576-5591
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Hyaluronan activated-metabolism phenotype (HAMP) in pancreatic ductal adenocarcinoma

Hyaluronan activated-metabolism phenotype (HAMP) in pancreatic ductal adenocarcinoma

https://doi.org/10.18632/oncotarget.27172

Yuzan Kudo, Shiro Kohi, Keiji Hirata, Michael Goggins,  and Norihiro Sato
5592-5604
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial

https://doi.org/10.18632/oncotarget.27188

Rajnish Nagarkar, Darshana Patil, Timothy Crook, Vineet Datta, Sagar Bhalerao, Sonal Dhande, Vijay Palwe, Shirsendu Roy, Prakash Pandit, Ashwini Ghaisas, Raymond Page, Harjeetsingh Kathuria, Ajay Srinivasan,  and Dadasaheb Akolkar
5605-5621
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Near-infrared fluorescence imaging and photodynamic therapy with indocyanine green lactosomes has antineoplastic effects for gallbladder cancer

Near-infrared fluorescence imaging and photodynamic therapy with indocyanine green lactosomes has antineoplastic effects for gallbladder cancer

https://doi.org/10.18632/oncotarget.27193

Hidehiko Hishikawa, Masaki Kaibori, Takumi Tsuda, Kosuke Matsui, Tadayoshi Okumura, Eiichi Ozeki,  and Kengo Yoshii
5622-5631
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Impact of exosomal HIV-1 Tat expression on the human cellular proteome

Impact of exosomal HIV-1 Tat expression on the human cellular proteome

https://doi.org/10.18632/oncotarget.27207

Huafei Lu, Xiaoli Tang, Mitchell Sibley, Jillian Coburn, R. Shyama Prasad Rao, Nagib Ahsan,  and Bharat Ramratnam
5632-5644
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma

Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma

https://doi.org/10.18632/oncotarget.27210

Kwang Woon Kim, Julia Y. Kim, Jingbo Qiao, Rachael A. Clark, Camille M. Powers, Hernan Correa,  and Dai H. Chung
5645-5659
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Meta-Analysis

Stereotactic body radiation therapy for prostate cancer: systematic review and meta-analysis of prospective trials

Stereotactic body radiation therapy for prostate cancer: systematic review and meta-analysis of prospective trials

https://doi.org/10.18632/oncotarget.27177

Taylor R. Cushman, Vivek Verma, Rahul Khairnar, Joseph Levy, Charles B. Simone 2nd,  and Mark V. Mishra
5660-5668
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Corrections

Correction: The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine

Correction: The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine

https://doi.org/10.18632/oncotarget.27216

Deok-Beom Jung, Miyong Yun, Eun-Ok Kim, Jaekwang Kim, Bonglee Kim, Ji Hoon Jung, Enfeng Wang, Debabrata Mukhopadhyay, Edward Hammond, Keith Dredge, Viji Shridhar,  and Sung-Hoon Kim
5669-5669
Correction  |  PDF  |  How to cite

Correction: mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development

Correction: mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development

https://doi.org/10.18632/oncotarget.27218

Laura Molina, Hong Yang, Adeola O. Adebayo Michael, Michael Oertel, Aaron Bell, Sucha Singh, Xin Chen, Junyan Tao,  and Satdarshan P. Monga
5670-5670
Correction  |  PDF  |  How to cite


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC